Hits 1-1 within 1 documents
Indirect costs of adult pneumococcal disease and the productivity-based rate of return to the 13-valent pneumococcal conjugate vaccine for adults in Turkey [journal article]
Source: Human Vaccines & Immunotherapeutics, 16 (2020) 8. p.1923-1936